| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Unipath Ltd. (F.M., J.C., P.W.P., J.E.E.), Bedford, United Kingdom MK44 3UP; Unilever Research Colworth (L.J.A.), Bedford, United Kingdom MK44 1LQ; and Parkwood Clinic (S.W.P.), Bournemouth, United Kingdom BH7 7DW
Address all correspondence and requests for reprints to: Dr. F. Miro, Unipath Ltd., Priory Business Park, Bedford, United Kingdom MK44 3UP. E-mail: fernando.miro{at}unipath.com.
The menopausal transition is characterized by the appearance of elongated cycles, which become longer and more frequent as menopause approaches. Several endocrine abnormalities have been attributed to these cycles; however, no quantitative studies of their causes and consequences exist to date. This study is based on sequential daily urinary concentrations of FSH, LH, estrone 3-glucuronide (E1G), and pregnanediol 3-glucuronide (PdG) from 34 women with perimenopausal menstrual irregularity (total of 289 cycles). The timing of ovarian response was determined as the day of E1G take-off (ETO). Other parameters measured were the mean FSH concentration before ETO (FSHETO) and the midluteal levels of PdG, E1G, and LH. There was a strong parallelism between ETO and cycle length variability. FSHETO levels increased gradually with ETO. Both ETO and FSHETO were inversely related to luteal PdG and directly related to E1G. PdG and LH levels were inversely related. All comparisons were highly significant (P < 0.0001). We conclude that delayed ovarian response underlies the elongation of the menstrual cycle in the menopausal transition, which is likely to be caused by a temporary lack of ovarian responsiveness to FSH. A progressive decline in luteal PdG with increased E1G occurs in association with these trends.
This article has been cited by other articles:
![]() |
K. A. O'Connor, R. J. Ferrell, E. Brindle, J. Shofer, D. J. Holman, R. C. Miller, D. E. Schechter, B. Singer, and M. Weinstein Total and Unopposed Estrogen Exposure across Stages of the Transition to Menopause Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 828 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Santoro, S. L. Crawford, W. L. Lasley, J. L. Luborsky, K. A. Matthews, D. McConnell, J. F. Randolph Jr., E. B. Gold, G. A. Greendale, S. G. Korenman, et al. Factors Related to Declining Luteal Function in Women during the Menopausal Transition J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1711 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.G. Burger, G.E. Hale, D.M. Robertson, and L. Dennerstein A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project Hum. Reprod. Update, November 1, 2007; 13(6): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Hale, X. Zhao, C. L. Hughes, H. G. Burger, D. M. Robertson, and I. S. Fraser Endocrine Features of Menstrual Cycles in Middle and Late Reproductive Age and the Menopausal Transition Classified According to the Staging of Reproductive Aging Workshop (STRAW) Staging System J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3060 - 3067. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Meyer, S. L. Zeger, S. D. Harlow, M. Sowers, S. Crawford, J. L. Luborsky, I. Janssen, D. S. McConnell, J. F. Randolph, and G. Weiss Characterizing Daily Urinary Hormone Profiles for Women at Midlife Using Functional Data Analysis Am. J. Epidemiol., April 15, 2007; 165(8): 936 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. MacGregor, A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study Neurology, December 26, 2006; 67(12): 2159 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.A. O'Connor, E. Brindle, R.C. Miller, J.B. Shofer, R.J. Ferrell, N.A. Klein, M.R. Soules, D.J. Holman, P.K. Mansfield, and J.W. Wood Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method Hum. Reprod., June 1, 2006; 21(6): 1442 - 1452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |